STAA Q1 2022 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$860M

Q1 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$63M+24.5% YoY

Gross Profit

$49M77.9% margin

Operating Income

$12M19.2% margin

Net Income

$10M15.2% margin

EPS (Diluted)

$0.19

QoQ Revenue Growth

+7.1%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$7M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$351M

Total Liabilities

$75M

Stockholders' Equity

$276M

Cash & Equivalents

$193M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$63M	$51M	+24.5%
Gross Profit	$49M	$39M	+25.9%
Operating Income	$12M	$7M	+62.2%
Net Income	$10M	$5M	+92.3%

Revenue Segments

Implantable Collamer Lenses

$59M93%

Cataract Intraocular Lenses

$3M5%

Other Surgical Products

$2M3%